The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1
Abstract
Purpose: The current study was designed to determine the risk of cancer in patients with neurofibromatosis type 1 (NF1) by cancer type, age, and sex with unprecedented accuracy to be achieved by combining two total population–based registers. Patients and Methods: A population-based series of patients with NF1 (N = 1,404; 19,076 person-years) was linked to incident cancers recorded in the Finnish Cancer Registry and deaths recorded in the national Population Register Centre between 1987 and 2012. Standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs) were calculated for selected cancer types. Survival of the patients with cancer with and without NF1 was compared. Results: In malignant peripheral nerve sheath tumors and CNS tumors, the cancers traditionally associated with NF1, we observed SIRs of 2,056 (95% CI, 1,561 to 2,658), and 37.5 (95% CI, 30.2 to 46.0), respectively, and SMRs of 2,301 (95% CI, 1,652 to 3,122) and 30.2 (95% CI, 19.1 to 45.2), respectively. We found an unequivocally increased risk for breast cancer. In particular, SIR was 11.1 (95% CI, 5.56 to 19.5) for breast cancer in women with NF1 age < 40 years; the overall SMR for breast cancer was 5.20 (95% CI, 2.38 to 9.88). Particularly high overall SIRs were observed in patients with NF1 age < 15 years: women, 87.6 (95% CI, 58.6 to 125); men, 45.6 (95% CI, 28.4 to 68.5). An estimated lifetime cancer risk for patients with NF1 was 59.6%. The 5-year survival of patients with cancer and NF1, excluding nervous tissue cancers, was worse than that of comparable patients with cancers without NF1 (54.0% v 67.5%; P = .01). Conclusion: Our results emphasize the general cancer proclivity of patients with NF1. These findings should translate to clinical practices to determine clinical interventions and focused follow-up of patients with NF1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Flexible regression models with cubic splines
Durrleman, S., & Simon, R. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080504 · Cited by 2,689
Tutorial in biostatistics: competing risks and multi‐state models
Putter, H., Fiocco, M., & Geskus, R. B. (2007) · Statistics in Medicine · doi:10.1002/sim.2712 · Cited by 2,440
Neurofibromatosis: Conference Statement
(1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520290115023 · Cited by 1,547
Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients
Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H. M., Saulino, A. M., Fountain, J. W., Brereton, A., Nicholson, J., Mitchell, A. L., et al. (1990) · Science · doi:10.1126/science.2134734 · Cited by 1,475
Von Recklinghausen Neurofibromatosis
Riccardi, V. M. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112313052704 · Cited by 1,344
Self-citationMalignant peripheral nerve sheath tumours in neurofibromatosis 1
Evans, D. G. R., Baser, M. E., McGaughran, J., Sharif, S., Howard, E., & Moran, A. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.5.311 · Cited by 1,282
The neurofibromatosis type 1 gene encodes a protein related to GAP
Xu, G., O'Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90024-9 · Cited by 1,095
Data Quality and Quality Control of a Population-Based Cancer Registry: Experience in Finland
Teppo, L., Pukkala, E., & Lehtonen, M. (1994) · Acta Oncologica · doi:10.3109/02841869409098430 · Cited by 642
Self-citationLong-Term Follow-up of von Recklinghausen Neurofibromatosis
Sørensen, S. A., Mulvihill, J. J., & Nielsen, A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604173141603 · Cited by 617
Listernick, R., Charrow, J., Greenwald, M., & Mets, M. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70122-9 · Cited by 548
Zöller, M. E. T., Rembeck, B., Odén, A., Samuelsson, M., & Angervall, L. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970601)79:11<2125::aid-cncr9>3.3.co;2-b · Cited by 395
VON RECKLINGHAUSEN′S DISEASE AND PHEOCHROMOCYTOMAS
Walther, M. M., Herring, J., Enquist, E., Keiser, H. R., & Linehan, W. M. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68171-2 · Cited by 361
Incidence and Mortality of Neurofibromatosis: A Total Population Study in Finland
Uusitalo, E., Leppävirta, J., Koffert, A., Suominen, S., Vahtera, J., Vahlberg, T., Pöyhönen, M., Peltonen, J., & Peltonen, S. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.465 · Cited by 308
Self-citationNeurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study
Stiller, C., Chessells, J., & Fitchett, M. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.431 · Cited by 287
Sharif, S., Moran, A., Huson, S. M., Iddenden, R., Shenton, A., Howard, E., & Evans, D. G. R. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.049346 · Cited by 242
A prospective study of neurofibromatosis type 1 cancer incidence in the UK
Walker, L., Thompson, D., Easton, D., Ponder, B., Ponder, M., Frayling, I., & Baralle, D. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603227 · Cited by 240
Seminog, O. O., & Goldacre, M. J. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.535 · Cited by 218
Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients
Maertens, O., Prenen, H., Debiec-Rychter, M., Wozniak, A., Sciot, R., Pauwels, P., De Wever, I., Vermeesch, J. R., de Raedt, T., De Paepe, A., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl016 · Cited by 214
Evans, D. G. R., O'Hara, C., Wilding, A., Ingham, S. L., Howard, E., Dawson, J., Moran, A., Scott-Kitching, V., Holt, F., & Huson, S. M. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.113 · Cited by 197
Gliomas in Neurofibromatosis Type 1: A Clinicopathologic Study of 100 Patients
Rodriguez, F. J., Perry, A., Gutmann, D. H., O'Neill, B. P., Leonard, J., Bryant, S., & Giannini, C. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318165eb75 · Cited by 190
Nguyen, R., Kluwe, L., Fuensterer, C., Kentsch, M., Friedrich, R. E., & Mautner, V.-F. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.04.008 · Cited by 159
Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1
Diggs‐Andrews, K. A., Brown, J. A., Gianino, S. M., Rubin, J. B., Wozniak, D. F., & Gutmann, D. H. (2013) · Annals of Neurology · doi:10.1002/ana.24093 · Cited by 152
Duong, T. A., Sbidian, É., Valeyrie‐Allanore, L., Viallette, C., Ferkal, S., Hadj-Rabia, S., Glorion, C., Lyonnet, S., Zérah, M., Kemlin, I., et al. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-18 · Cited by 134
Malignant peripheral nerve sheath tumours in inherited disease
Evans, D. G., Huson, S., & Birch, J. M. (2012) · Clinical Sarcoma Research · doi:10.1186/2045-3329-2-17 · Cited by 123
Malignant peripheral nerve sheath tumours in NF1: Improved survival in women and in recent years
Ingham, S. L., Huson, S., Moran, A., Wylie, J. P., Leahy, M. G., & Evans, D. G. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.05.031 · Cited by 38
Neoplasms in neurofibromatosis 1 are related to gender but not to family history of cancer
Airewele, G. E., Sigurdson, A. J., Wiley, K. J., Frieden, B. E., Caldarera, L. W., Riccardi, V. M., Lewis, R. A., Chintagumpala, M., Ater, J. L., Plon, S. E., et al. (2000) · Genetic Epidemiology · doi:10.1002/1098-2272(200101)20:1<75::aid-gepi7>3.0.co;2-z · Cited by 32
Self-citation
Cited by
RAS Proteins and Their Regulators in Human Disease
Simanshu, D. K., Nissley, D. V., & McCormick, F. (2017) · Cell · doi:10.1016/j.cell.2017.06.009 · Cited by 1,943
Gutmann, D. H., Ferner, R. E., Listernick, R. H., Korf, B. R., Wolters, P. L., & Johnson, K. J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.4 · Cited by 862
Legius, E., Messiaen, L., Wolkenstein, P., Pancza, P., Avery, R. A., Berman, Y., Blakeley, J., Babovic-Vuksanovic, D., Cunha, K. S., Ferner, R., et al. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01170-5 · Cited by 825
Self-citationNCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
Daly, M. B., Pilarski, R., Berry, M., Buys, S. S., Farmer, M., Friedman, S., Garber, J. E., Kauff, N. D., Khan, S., Klein, C., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0003 · Cited by 650
UK guidelines for the management of soft tissue sarcomas
Dangoor, A., Seddon, B., Gerrand, C., Grimer, R., Whelan, J., & Judson, I. (2016) · Clinical Sarcoma Research · doi:10.1186/s13569-016-0060-4 · Cited by 477
Metadata
- Authors
- Uusitalo, E., Rantanen, M., Kallionpää, R. A., Pöyhönen, M., Leppävirta, J., Ylä-Outinen, H., Riccardi, V. M., Pukkala, E., Pitkäniemi, J., Peltonen, S., & Peltonen, J.
- Venue
- Journal of Clinical Oncology
- Published
- 2016-06-10
- Volume
- 34
- Issue
- 17
- Pages
- 1978-1986
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2291991964
- Cited by
- 418
- References
- 28
- FWCI
- 17.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.